Bluetongue virus (BTV) produces an economically important disease in ruminants of compulsory notification to the OIE. BTV is typically transmitted by the bite of spp., however, some BTV strains can be transmitted vertically, and this is associated with fetus malformations and abortions. The viral factors associated with the virus potency to cross the placental barrier are not well defined. The potency of vertical transmission is retained and sometimes even increased in live attenuated BTV vaccine strains. Because BTV possesses a segmented genome, the possibility of reassortment of vaccination strains with wild-type virus could even favor the transmission of this phenotype. In the present review, we will describe the non-vector-based BTV infection routes and discuss the experimental vaccination strategies that offer advantages over this drawback of some live attenuated BTV vaccines.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622840 | PMC |
| http://dx.doi.org/10.3390/pathogens10111528 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Complete mitochondrial genomes of and biting midge vectors of Bluetongue Virus.
Mitochondrial DNA B Resour
January 2025
CSIRO Environment, Black Mountain, ACT, Australia.
Biting midges ( spp.) are important vectors of several insect borne arboviruses but are underrepresented in terms of availability of high-resolution genomic resources. We assembled and annotated complete mitochondrial genomes for two species, namely and which are proven vectors for Bluetongue Virus (BTV).
View Article and Find Full Text PDFEmergence of Bluetongue Virus Serotype 3 in Portugal (2024).
Viruses
November 2024
Virology Laboratory, Nacional Institute of Agrarian and Veterinarian Research, Quinta Do Marquês, Av. da República, 2780-157 Oeiras, Portugal.
Article Synopsis
- Bluetongue virus serotype 3 (BTV-3) was detected in Portugal's Alentejo region in September 2024, first identified in a sheep showing severe symptoms like head swelling and respiratory issues.
- Two cases were confirmed within the same area, leading to high mortality rates in affected livestock.
- In light of the rapid spread of BTV-3, monitoring and vaccination campaigns are underway to protect livestock health and control the virus's transmission.
Challenges of BTV-Group Specific Serology Testing: No One Test Fits All.
Viruses
November 2024
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Animal Health Laboratory, Australian Centre for Disease Preparedness, 5 Portarlington Road, East Geelong, VIC 3219, Australia.
A newly formatted enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to bluetongue virus (BTV) was developed and validated for bovine and ovine sera and plasma. Validation of the new sandwich ELISA (sELISA) was achieved with 949 negative bovine and ovine sera from BTV endemic and non-endemic areas of Australia and 752 BTV positive (field and experimental) sera verified by VNT and/or PCR. The test diagnostic sensitivity (DSe) and diagnostic specificity (DSp) were 99.
View Article and Find Full Text PDFDevelopment and Evaluation of a Candidate Inactivated Vaccine Against Bluetongue Virus Serotype 4 (BTV4).
Vaccines (Basel)
November 2024
Institute of Veterinary Medicine of Serbia, Janisa Janulisa 14, 11000 Belgrade, Serbia.
Objectives: Although bluetongue is not a contagious disease, it is easily transmitted and spread by appropriate insect vectors, causing great economic damage. Climate change has led to the fact that vectors and diseases have spread to the top of Northern Europe, causing great economic losses in livestock production. An even greater problem is controlling the disease, because numerous species of domestic and wild ruminants are susceptible to bluetongue.
View Article and Find Full Text PDFBluetongue virus serotype 12 in sheep and cattle in the Netherlands in 2024 - A BTV serotype reported in Europe for the first time.
Vet Microbiol
December 2024
Wageningen Bioveterinary Research (WBVR), Department of Virology, P.O. Box 65, Lelystad 8200 AB, the Netherlands.
Bluetongue (BT) is a viral vector borne disease primarily affecting ruminants such as sheep, cattle, and goats. On 3 September 2023, the Netherlands reported the first case of bluetongue virus serotype 3 (BTV-3/NET2023)), after being BTV free for eleven years. Vaccination with inactivated BT vaccines for serotype 3 has been applied in the Netherlands since May 2024.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!